Experience

Davis Polk advised the joint global coordinators, joint bookrunners and co-lead manager in the initial public offering of 57,518,970 shares of Nordax Group AB (publ) (“Nordax”) on Nasdaq…

Davis Polk advised Biotie Therapies Corp. (“Biotie”) on its $56.7 million U.S. initial public offering of 3,806,047 American Depositary Shares (“ADSs”) representing 304,483,760 ordinary…

Davis Polk advised the dealers of a senior unsecured Rule 144A/Regulation S offering by Crédit Agricole S.A. (“Crédit Agricole”), as issuer, acting through its London branch, of series no…

Davis Polk advised Markit Ltd. in connection with its SEC-registered secondary offering of 27,501,271 common shares sold by 15 selling shareholders, including 1,754,667 shares sold upon the…

Davis Polk advised the managers of the Rule 144A/Regulation S offering by NXP B.V. and NXP Funding LLC of $600 million principal amount of 4.125% senior notes due 2020 and $400 million…

Davis Polk advised the joint book-running managers of a $1 billion SEC-registered offering by ArcelorMittal consisting of $500 million aggregate principal amount of 5.125% notes due 2020…

Davis Polk advised the joint book-running managers on the Rule 144A/Regulation S offering by Skandinaviska Enskilda Banken AB (publ) of $1 billion aggregate principal amount of 2.45% notes…

Davis Polk advised the underwriters in connection with an SEC-registered offering by Aon plc of $600 million aggregate principal amount of 4.750% senior notes due 2045. The notes are…

Davis Polk advised the several underwriters, in connection with Galapagos NV’s global offering of 7,532,499 of its ordinary shares. The offering consisted of an underwritten public…

Davis Polk advised the joint book-running managers on an offering of $850 million aggregate principal amount of 3.625% senior notes due 2020 and $650 million aggregate principal amount of 4…